Children’s did not say what led to Mr. Tiedemann’s departure, but his tenure since arriving in 2005 was marked by a failed bond issue and rumors that the hospital would leave Oakland.
Dr. Lubin has been senior vice president of research at Children’s and built the hospital’s Research Institute, which specializes in sickle cell disease, diabetes, obesity, cancer and birth defects.
Read San Francisco Business Times report about the new Children’s Hospital CEO.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
